MultiPlan Corporation reported a 1.3% increase in revenues to $244.1 million for Q4 2023, with a net loss of $31.4 million and an adjusted EBITDA of $156.8 million. The company identified $5.9 billion in potential medical cost savings during the quarter.
Q4 2023 revenues increased by 1.3% year-over-year to $244.1 million.
Net loss for Q4 2023 was $31.4 million, an improvement compared to the $650.1 million net loss in Q4 2022.
Adjusted EBITDA for Q4 2023 totaled $156.8 million.
Identified potential medical cost savings of approximately $5.9 billion in Q4 2023, up 9.4% from Q4 2022.
MultiPlan anticipates full year 2024 revenues between $1,000 million and $1,030 million and Adjusted EBITDA between $630 million and $650 million. The Company anticipates Q1 2024 revenues between $235 million and $250 million and Adjusted EBITDA between $150 million and $160 million.
Analyze how earnings announcements historically affect stock price performance